Publications - Articles (1993-2008)
Strategy ethical products
|
- Building prescriber loyalty
- ACE-inhibitors - An analysis of marketing strategy
- Are generic defense strategies worth the effort?
- Winning strategies in the French hospital market
- Making the most of maturity
- The end of the back-up brands?
- Financial requirements of immunization programs in developing countries: a 2004-2014 perspective
- Les marques sont-elles condamnées à mourir ?
|
Strategy OTC & supplements
|
- Assessing the OTC market in France
- How bright are the prospects for self-medication in France?
- Thin pickings in dietary supplements
- Should big pharma sell its OTC business?
- Automédication : quel attrait pour le marché mondial ?
- Des stratégies opposées pour les « big pharma »
- Le switch, solution ou danger ?
|
Strategy vs. generics
|
- Entering the French generics market
- Is the sun rising for Japanese generics?
- Can generics really help to curb French healthcare costs?
- Lighting fire from wet timber in French generics market
- How bright is the future for generics?
- Barriers to substitution
- What is the value of authorised generics agreements? Assessments on the French market
- Princeps - Génériques : Faut-il pactiser avec l’ennemi ?
- Quelles perspectives pour les génériques?
- L'avenir mouvementé du marché mondial des génériques
|
Environment
|
- Survival strategies in contract sales organizations
- Changes at the French pharmacy
- Drug reimbursement harmonization in Europe
- Disease management opportunities in France
- Working with the authorities
- La réputation d'entreprise, un nouvel enjeu stratégique
|
Operational effectiveness
|
- Heading for change : marketing and sales trends in France
- Counting the cost of purchase
- The brave new world of Corporate Marketing
- Talking up sales
- Le BPS, pour la "justesse de voix"
|
To receive a reprint, send your request to jmpeny@smart-pharma.com.
